Stem cell treatment for mild-moderate Alzheimer's
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new stem cell treatment (called RB-ADSCs) that is injected into the fluid around your brain. It aims to see if these cells can help slow down memory loss and thinking problems in people with mild to moderate Alzheimer's disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 85 years old.
- You have mild to moderate Alzheimer's disease (confirmed by memory tests and a special brain scan).
- You have a caregiver who can join you in the study.
- You have not had cancer in the last 5 years.
- You are not taking any medications that are not allowed for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether injecting your own (autologous) activated fat-derived stem cells into the brain is safe and potentially helpful for mild to moderate Alzheimer’s disease. The goal is to see how the treatment affects the brain and symptoms, using cells made from your own donated fat tissue.
This trial tests whether stem cells from donated fat tissue can help people with mild to moderate Alzheimer's disease. It combines infusions of these cells with standard care, and includes brain scans and memory tests to see if the treatment is safe and effective.
This trial is a follow-up for people who already received a single dose of RB-ADSC (a stem cell treatment) in an earlier study. It tests whether more doses, given through a small brain injection, are safe and might help with Alzheimer's.
This Phase 2 study tests whether sargramostim (a GM-CSF related medicine) is safe and can slow or improve Alzheimer’s symptoms. You might be a good fit if you have mild or moderate Alzheimer’s, positive amyloid testing, and can complete frequent visits with a close caregiver who knows you well.
This trial tests whether a gentle, non-invasive brain stimulation (transcranial alternating current) can improve memory and thinking in people with early Alzheimer's or mild memory problems. It involves regular sessions of stimulation and check-ups over several months.
This trial tests a new, noninvasive treatment that combines magnetic and electrical stimulation to target a specific brain network in people with mild Alzheimer's disease. It aims to slow memory decline and improve brain function.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.